Biolase (BIOL)

Biolase Financial Statements


Biolase Financial Overview

Biolase's market cap is currently ―. The company's EPS TTM is $-3.117; its P/E ratio is -1.39; Biolase is scheduled to report earnings on November 16, 2022, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 12.23M$ 10.17M$ 12.41M$ 9.53M$ 9.13M
Gross Profit$ 5.14M$ 4.73M$ 4.91M$ 4.84M$ 4.04M
EBIT$ -5.16M$ -4.33M$ -4.71M$ -2.69M$ -200.00K
EBITDA$ -5.03M$ -4.21M$ -4.59M$ -2.59M$ -109.00K
Net Income Common Stockholders$ -5.61M$ -4.99M$ -5.28M$ -3.29M$ -708.00K
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 17.56M$ 18.85M$ 19.55M$ 21.61M$ 29.97M
Total Assets$ 50.85M$ 50.24M$ 55.28M$ 58.51M$ 61.25M
Total Debt$ 5.30M$ 14.01M$ 14.71M$ 14.85M$ 15.64M
Net Debt$ -12.26M$ -4.84M$ -4.84M$ -6.75M$ -14.33M
Total Liabilities$ 29.24M$ 29.64M$ 30.08M$ 28.19M$ 27.99M
Stockholders Equity$ 10.03M$ 13.85M$ 20.60M$ 21.61M$ 25.21M
Cash Flow
Free Cash Flow$ -6.89M$ -8.32M$ -3.42M$ -3.68M$ -3.81M
Operating Cash Flow$ -6.61M$ -8.02M$ -3.10M$ -3.60M$ -3.51M
Investing Cash Flow$ -274.00K$ -304.00K$ -311.00K$ -85.00K$ -303.00K
Financing Cash Flow$ 4.85M$ 0.00$ 68.00K$ 75.00K$ -14.00K
Currency in USD

Biolase Earnings and Revenue History

Biolase Debt to Assets

Biolase Cash Flow

Biolase Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis